Manhattan Scients Stock Probability of Future Pink Sheet Price Finishing Over 7.81E-4

MHTX Stock  USD 0.0009  0.0001  12.50%   
Manhattan Scients' future price is the expected price of Manhattan Scients instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Manhattan Scients performance during a given time horizon utilizing its historical volatility. Check out Manhattan Scients Backtesting, Manhattan Scients Valuation, Manhattan Scients Correlation, Manhattan Scients Hype Analysis, Manhattan Scients Volatility, Manhattan Scients History as well as Manhattan Scients Performance.
  
Please specify Manhattan Scients' target price for which you would like Manhattan Scients odds to be computed.

Manhattan Scients Target Price Odds to finish over 7.81E-4

The tendency of Manhattan Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 0.0008  in 90 days
 0.0009 90 days 0.0008 
about 86.14
Based on a normal probability distribution, the odds of Manhattan Scients to stay above $ 0.0008  in 90 days from now is about 86.14 (This Manhattan Scients probability density function shows the probability of Manhattan Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Manhattan Scients price to stay between $ 0.0008  and its current price of $9.0E-4 at the end of the 90-day period is about 17.72 .
Given the investment horizon of 90 days Manhattan Scients has a beta of 0.64. This indicates as returns on the market go up, Manhattan Scients average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Manhattan Scients will be expected to be much smaller as well. Additionally Manhattan Scients has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Manhattan Scients Price Density   
       Price  

Predictive Modules for Manhattan Scients

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Manhattan Scients. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Manhattan Scients' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.00011.71
Details
Intrinsic
Valuation
LowRealHigh
0.000.000911.71
Details

Manhattan Scients Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Manhattan Scients is not an exception. The market had few large corrections towards the Manhattan Scients' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Manhattan Scients, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Manhattan Scients within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.19
β
Beta against Dow Jones0.64
σ
Overall volatility
0.0002
Ir
Information ratio -0.02

Manhattan Scients Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Manhattan Scients for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Manhattan Scients can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Manhattan Scients had very high historical volatility over the last 90 days
Manhattan Scients has some characteristics of a very speculative penny stock
Manhattan Scients has a very high chance of going through financial distress in the upcoming years
Manhattan Scients currently holds 143 K in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Manhattan Scients has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Manhattan Scients until it has trouble settling it off, either with new capital or with free cash flow. So, Manhattan Scients' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Manhattan Scients sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Manhattan to invest in growth at high rates of return. When we think about Manhattan Scients' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 50 K. Net Loss for the year was (3.64 M) with profit before overhead, payroll, taxes, and interest of 50 K.
Manhattan Scients currently holds about 386 K in cash with (421 K) of positive cash flow from operations.
Roughly 19.0% of Manhattan Scients outstanding shares are owned by corporate insiders

Manhattan Scients Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Manhattan Pink Sheet often depends not only on the future outlook of the current and potential Manhattan Scients' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Manhattan Scients' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding559.3 M

Manhattan Scients Technical Analysis

Manhattan Scients' future price can be derived by breaking down and analyzing its technical indicators over time. Manhattan Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Manhattan Scients. In general, you should focus on analyzing Manhattan Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Manhattan Scients Predictive Forecast Models

Manhattan Scients' time-series forecasting models is one of many Manhattan Scients' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Manhattan Scients' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Manhattan Scients

Checking the ongoing alerts about Manhattan Scients for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Manhattan Scients help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Manhattan Scients had very high historical volatility over the last 90 days
Manhattan Scients has some characteristics of a very speculative penny stock
Manhattan Scients has a very high chance of going through financial distress in the upcoming years
Manhattan Scients currently holds 143 K in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Manhattan Scients has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Manhattan Scients until it has trouble settling it off, either with new capital or with free cash flow. So, Manhattan Scients' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Manhattan Scients sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Manhattan to invest in growth at high rates of return. When we think about Manhattan Scients' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 50 K. Net Loss for the year was (3.64 M) with profit before overhead, payroll, taxes, and interest of 50 K.
Manhattan Scients currently holds about 386 K in cash with (421 K) of positive cash flow from operations.
Roughly 19.0% of Manhattan Scients outstanding shares are owned by corporate insiders

Additional Tools for Manhattan Pink Sheet Analysis

When running Manhattan Scients' price analysis, check to measure Manhattan Scients' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Manhattan Scients is operating at the current time. Most of Manhattan Scients' value examination focuses on studying past and present price action to predict the probability of Manhattan Scients' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Manhattan Scients' price. Additionally, you may evaluate how the addition of Manhattan Scients to your portfolios can decrease your overall portfolio volatility.